Efficacy of treatment after measurable diabeticlike retinopathy in galactose-fed rats

Investigative Ophthalmology and Visual Science

Volumn 38, Issue 6, 1997, Pages 1066-1073

  Robison Jr , W Gerald ^a   Laver, Nora M ^a,b   Jacot, Jorge L ^a   Chandler, Michael L ^c   York, Billie M ^c   Glover, Joel P ^a  

^a NATIONAL EYE INSTITUTE   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ALCON RESEARCH LTD   (United States)

Author keywords

aldose reductase; computer morphometry; diabetic retinopathy; galactose fed rat model; intervention therapy; retinal vasculature

Indexed keywords

AL 3152; ALDOSE REDUCTASE INHIBITOR; GALACTOSE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY BASEMENT MEMBRANE; CAPILLARY DENSITY; CARBOHYDRATE DIET; CONTROLLED STUDY; DIABETIC MICROANGIOPATHY; DIABETIC RETINOPATHY; DIET RESTRICTION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

ALDEHYDE REDUCTASE; ANIMALS; DIABETIC RETINOPATHY; DIET; ENZYME INHIBITORS; FLUORENES; GALACTOSE; HYDANTOINS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MICROSCOPY, ELECTRON; RATS; RATS, SPRAGUE-DAWLEY; REFERENCE VALUES; RETINA; RETINAL VESSELS;

EID: 1842414865     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Frank RN, Keirn RJ, Kennedy A, Frank KW. Galactose- induced retinal capillary basement membrane thickening: Prevention by sorbinil. Invest Ophthalmol Vis Sci. 1983;24:1519-1524.
2. Robison WG Jr, Kador PF, Kinoshita JH. Retinal capillaries: Basement membrane thickening by galactosemia prevented with aldose reductase inhibitor. Science. 1983;221:1177-1179.
3. Robison WG Jr, Nagata M, Laver N, Hohman TC, Kinoshita JH. Diabetic-like retinopathy in rats prevented with an aldose reductase inhibitor. Invest Ophthalmol Vis Sci. 1989;30:2285-2292.
4. Robison WG Jr, Tillis TN, Laver N, Kinoshita JH. Diabetes-related histopathologies of the rat retina prevented with an aldose reductase inhibitor. Exp Eye Res. 1990;50:355-366.
5. Robison WG Jr, Laver NM, Jacot JL, Glover JP. Sorbinil prevention of diabetic-like retinopathy in the galactose-fed rat model. Invest Ophthalmol Vis Sci. 1995;36:2368-2380.
6. Robison WG Jr, Laver NM, Jacot JL, et al. Diabeticlike retinopathy ameliorated with the aldose reductase inhibitor WAY-121,509. Invest Ophthalmol Vis Sci. 1996;37:1149-1156.
7. Kador PF, Akagi Y, Takahashi Y, Ikebe H, Wyman M, Kinoshita JH. Prevention of retinal vessel changes associated with diabetic retinopathy in galactose-fed dogs by aldose reductase inhibitors. Arch Ophthalmol. 1990;108:1301-1309.
8. Kador PF, Takahashi Y, Sato S, Wyman M. Amelioration of diabetes-like retinal changes in galactose-fed dogs. Prev Med. 1994;23:717-721.
9. Takahashi Y, Wyman M, Ferns F III, Kador PF. Diabeteslike preproliferative retinal changes in galactosefed dogs. Arch Ophthalmol. 1992;110:1295-1302.
10. Takahashi Y, Augustin W, Wyman M, Kador PF. Quantitative analysis of retinal vessel changes in galactosefed dogs. J Ocular Pharmacol. 1993;9:257-269.
11. Robison WG Jr, Kador PF, Akagi Y, Kinoshita JH, Gonzalez R, Dvornik D. Prevention of basement membrane thickening in retinal capillaries by a novel inhibitor of aldose reductase, tolrestat. Diabetes. 1986;35: 295-299.
12. Robison WG Jr, Nagata M, Kinoshita JH. Aldose reductase and retinal capillary basement membrane thickening. Exp Eye Res. 1988;46:343-348.
13. Robison WG Jr, Laver NM. Ocular lesions in animal models of human diabetes. In: Shafrir E, ed. Frontiers in Diabetes Research, Lessons from Animal Diabetes IV. Biennial Review Volume: 1992. London: Smith-Gordon; 1993:145-163.
14. Robison WG Jr, Laver NM, Lou MF. The role of aldose reductase in diabetic retinopathy: Prevention and intervention studies. In: Osborne NN, Chader GJ, eds. Progress in Retinal and Eye Research v. 14. Oxford: Pergamon; 1995:593-640.
15. Reddy VN, Lin L-R, Giblin FJ, Lou M, Kador PF, Kinoshita JH. The efficacy of aldose reductase inhibitors on polyol accumulation in human lens and retinal pigment epithelium in tissue culture. J Ocular Pharmacol. 1992;8:43-52.
16. Park YH, Mayer PR, Barker R, et al. Comparison of the pharmacokinetics and pharmacodynamics of the aldose reductase inhibitors, AL03152 (RS), AL03802 (R), and AL03803 (S). Pharm Res. 1993;10:593-597.
17. Laver NM, Robison WG Jr, Pfeffer BA. Novel procedures for isolating intact retinal vascular beds from diabetic humans and animal models. Invest Ophthalmol Vis Sci. 1993;34:2097-2104.
18. McCaleb ML, McKean ML, Hohman TC, Laver N, Robison WG Jr. Intervention with the aldose reductase inhibitor, tolrestat, in renal and retinal lesions of streptozotocindiabetic rats. Diabetologia. 1991;34:695-701.
19. Engerman RL, Kern TS. Progression of incipient diabetic retinopathy during good glycemic control. Diabetes. 1987;36:808-812.
20. Engerman RL, Kern TS. Retinopathy in galactosemic dogs continues to progress after cessation of galactosemia. Arch Ophthalmol. 1995;113:355-358.
21. Aiello LM. Diagnosis, management, and treatment of nonproliferative diabetic retinopathy and macular edema. In: Albert DM, Jakobiec FA, eds. Principles and Practice of Ophthalmology, Clinical Practice. Philadelphia: WB Saunders and Company; 1994:747-760.
22. Early Treatment Diabetic Retinopathy Study (ETDRS) Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs - An extension of the modified Airlie House classification. ETDRS Report Number 10. Ophthalmology. 1991;98: 786-806.
23. Early Treatment Diabetic Retinopathy Study (ETDRS) Research Group. Fundus photographic risk factors for progression of diabetic retinopathy, ETDRS Report Number 12. Ophthalmology, 1991;98:823-833.
24. Speakman JS, Mortimer CB, Briant TDR, Ezrin C, Lougheed WM, Clarke WTW. Pituitary ablation for diabetic retinopathy. Can Med Assoc J. 1966;94:627- 635.
25. Chakrabarti S, Sima AAF, Tze WJ, Tai J. Prevention of diabetic retinal capillary pericyte degeneration and loss by pancreatic islet allograft. Curr Eye Res. 1987;6:649-658.
26. Petersen MR, Vine AK, The University of Michigan Pancreas Transplant Evaluation Committee. Progression of diabetic retinopathy after pancreas transplantation. Ophthalmology. 1990;97:496-502.
27. Engerman RL, Kern TS. Aldose reductase inhibition fails to prevent retinopathy in diabetic and galactosemic dogs. Diabetes. 1993;42:820-825.
28. Kern TS, Engerman RL. Galactose-induced retinal microangiopathy in rats. Invest Ophthalmol Vis Sci. 1995; 36:490-496.
29. Robison WG Jr. Aldose reductase inhibition and retinopathy. Diabetes. 1994;43:337-338.
30. Robison WG Jr. Diabetic retinopathy: Galactose-fed rat model. Letter to the Editor. Invest Ophthalmol Vis Sci. 1995;36:4A-1744.
31. Crabbe MJC, Goode D, Wolff SP. Aldose reductase: Black sheep or skeleton in the cupboard? Nat Struct Biol. 1996;3:659-661.
32. Robison WG Jr, Kuwabara T, Bieri JG. Vitamin E deficiency and the retina: Photoreceptor and pigment epithelial changes. Invest Ophthalmol Vis Sci. 1979;18: 683-690.
33. Garner A. Vascular diseases. In: Garner A, Klintworth GK, eds. Pathobiology of Ocular Disease. A Dynamic Approach. 2nd ed. Part B. New York: Marcel Dekker; 1994:1625-1710.
34. Hu T-S, Datiles M, Kinoshita JH. Reversal of galactose cataract with sorbinil in rats. Invest Ophthalmol Vis Sci. 1983:24:640-644.
35. Simard-Duquesne N, Dvornik D, Galactitol accumulation and irreversible lens opacities in galactosemic rats. Invest Ophthalmol Vis Sci. 1973;12:82-83.
36. Engerman RL, Pfaffenbach D, Davis MD. Cell turnover of capillaries. Lab Invest. 1967;17:738-743.
37. Orlidge A, D'Amore PA. Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells. J Cell Biol. 1987;105:1455-1462.
38. Speiser P, Gittelsohn AM, Patz A. Studies on diabetic retinopathy, III. Influence of diabetes on intramural pericytes. Arch Ophthalmol. 1968;80:332-337.
39. The Diabetes Control and Complications Trial (DCCT) Research Group. The effect of intensive treatment of diabetes on the development and progression of longterm complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.